Advertisement

Topics

Synergy Pharmaceuticals Reports Fourth Quarter and Full Year 2016 Financial Results and Business Update

16:42 EST 1 Mar 2017 | Businesswire

This article has expired, however you can still download the PDF.
Preview:
Synergy Pharmaceuticals Inc. (NASDAQ:SGYP), a biopharmaceutical company focused on the development and commercialization of novel gastrointestinal (GI) therapies, today reported its financial results and business update for the ...

Other Sources for this Article

Synergy Pharmaceuticals Inc.
Gem Hopkins, 212-584-7610
VP, Investor Relations and Corporate Communications
ghopkins@synergypharma.com

NEXT ARTICLE

More From BioPortfolio on "Synergy Pharmaceuticals Reports Fourth Quarter and Full Year 2016 Financial Results and Business Update"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Healthcare
Health care (or healthcare) is the diagnosis, treatment, and prevention of disease, illness, injury, and other physical and mental impairments in humans. Health care is delivered by practitioners in medicine, chiropractic, dentistry, nursing, pharmacy, a...